Attached files
| file | filename |
|---|---|
| EX-17.1 - Sanara MedTech Inc. | wmti8kex171053012.htm |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 29, 2012
Wound Management Technologies, Inc.
(Exact name of registrant as specified in its charter)
|
Texas
|
0-11808
|
59-2219994
|
|
(State or other jurisdiction
|
(Commission File
|
(IRS Employer
|
|
incorporation)
|
Number)
|
Identification No.)
|
|
777 Main Street, Suite 3100, Fort Worth, Texas
|
76102
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code 817-820-7080
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
[_]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
[_]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[_]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
[_]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.
On May 25, 2012, Scott A. Haire informed Wound Management Technologies, Inc. (the "Company') that he would be resigning from his positions as a member of the Company's Board of Directors and as the Company's Chief Financial Officer. His resignation was effective as of May 25, 2012. A copy of Mr. Haire's letter of resignation has been filed with this form as Exhibit 17.1.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Exhibit.
No. Description
17.1 Resignation Letter of Scott A. Haire, dated May 25, 2012
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: May 29, 2012
|
WOUND MANAGEMENT TECHNOLOGIES, INC.
|
|
/s/ Robert Lutz, Jr.
|
|
|
Robert Lutz, Jr., Chief Executive Officer
|